Outlining four developments set to change how life-sciences organizations design, deploy, and govern intelligent systems in the year ahead.

Life sciences had a rough 2025 — the least active IPO market in over a decade — but AI adoption across the sector accelerated anyway. Problem is, the governance infrastructure is still being built ...

Life sciences leaders say AI agents will be "essential" within two years. 97% say trusted data is essential for effective use of AI agents. 81% of R&D leaders surveyed are "very excited" about using ...